Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−41.72 MHKD
862.59 MHKD
305.85 M
Om TOT BIOPHARM INTL CO LTD
Sektor
Bransch
VD
Jun Liu
Webbplats
Huvudkvarter
Suzhou
Grundat
2009
ISIN
HK0000545266
FIGI
BBG00QQ11Q39
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
